Cabaletta Bio, Inc. (CABA) Deep Dive Video

Summary

A discounted autoimmune CAR‑T “immune reset” pioneer with multiple pivotal shots on goal—if safety, scale, and funding hold, rese‑cel could redefine chronic autoimmune care.

View CABA stock page · Read the CABA research report

Loading the video player…